Xuechun Wang

机构：Fujian Medical University, Ministry of Education of the People's Republic of China, Shanghai Jiao Tong University, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking University, Society for Maternal-Fetal Medicine, ShanghaiTech University, Shanghai Ninth People's Hospital, Fuzhou Maternity and Child Health Care Hospital, Peking University Sixth Hospital, Nanjing Medical University · ORCID：0000-0003-4754-186X

发表论文 74 篇 · 总被引 842 次 · h-index 17

代表论文

• Reteplase versus Alteplase for Acute Ischemic Stroke (2024 · New England Journal of Medicine · 被引 96)
• Safety and efficacy of intravenous recombinant human prourokinase for acute ischaemic stroke within 4·5 h after stroke onset (PROST-2): a phase 3, open-label, non-inferiority, randomised controlled trial (2024 · The Lancet Neurology · 被引 42)
• NTIRE 2024 Challenge on Light Field Image Super-Resolution: Methods and Results (2024 · 被引 28)
• Association of DNA methylation/demethylation with the functional outcome of stroke in a hyperinflammatory state (2024 · Neural Regeneration Research · 被引 17)
• Segmentation of infarct lesions and prognosis prediction for acute ischemic stroke using non-contrast CT scans (2024 · Computer Methods and Programs in Biomedicine · 被引 11)
• Discovery of HZS60 as a Novel Brain Penetrant NMDAR/TRPM4 Interaction Interface Inhibitor with Improved Activity and Pharmacokinetic Properties for the Treatment of Cerebral Ischemia (2025 · Journal of Medicinal Chemistry · 被引 10)